Rockbridge Investment Management, Lcc Bristol Myers Squibb CO Transaction History

Rockbridge Investment Management, Lcc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $50,516 - $60,279	-1,042 Reduced 61.8%	644 $33 Million
Q3 2022 May 28, 2024	SELL	$0.13 - $76.84 $102 - $60,780	-791 Closed	0 $0
Q2 2022 May 28, 2024	SELL	$72.62 - $79.98 $30,863 - $33,991	-425 Reduced 34.95%	791 $60,000
Q1 2022 May 28, 2024	BUY	$61.48 - $73.72 $74,759 - $89,643	1,216 New	1,216 $88,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $35,502 - $41,586	600 Added 55.25%	1,686 $99,000
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $6,191 - $6,742	100 Added 10.14%	1,086 $73,000
Q1 2021 May 20, 2021	SELL	$59.34 - $66.74 $77,142 - $86,762	-1,300 Reduced 56.87%	986 $62,000
Q2 2020 Aug 20, 2020	BUY	$54.82 - $64.09 $125,318 - $146,509	2,286 New	2,286 $134,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.